Piscataway, NJ, April 30, 2018– Camber Pharmaceuticals is pleased to announce the addition of Methylphenidate Chewable Tablet to our growing portfolio of products.
Methylphenidate Chewable tablet is the generic version of Methylin®. Methylphenidate is used to treat attention deficit hyperactivity disorder- ADHD.
Methylphenidate Chewable tablets are available in 2.5, 5 and 10mg 100ct bottles.
Camber’s commitment to its customers is to bring the highest quality generic pharmaceuticals to the market and provide a level of excellence in service, supply and affordability.
If you would like more information about this topic, please contact Kirk Hessels at 732.529.0430 or email at [email protected]
- 28 New Generics in 2022 and Anticipates Record Number of Approvals in 2023
- Camber Pharmaceuticals Launches Generic Cambia®
- Camber Pharmaceuticals Launches Generic Kuvan® Tablets and Powder for Oral Solution
- Camber Pharmaceuticals Launches Generic Vimpat® Injection
- Camber Pharmaceuticals Launches Generic Naprosyn®
- Camber Pharmaceuticals Launches Generic Lamictal XR®